Seminars in Hematology
Volume 40, Issue 2 , Pages 116-123, April 2003

Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases☆☆☆

Medical Virology Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Address correspondence to Jeffrey I. Cohen, MD, Laboratory of Clinical Investigation, National Institutes of Health, Bldg 10, Room 11N214, 10 Center Dr, Bethesda, MD 20892-1888.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This is a US government work. There are no restrictions on its use.

☆☆ 0037-1963/03/4002-0002$0.00/0

PII: S0037-1963(03)70003-1

Seminars in Hematology
Volume 40, Issue 2 , Pages 116-123, April 2003

Article Tools